Uhl G R, Javitch J A, Snyder S H
Lancet. 1985 Apr 27;1(8435):956-7. doi: 10.1016/s0140-6736(85)91729-5.
MPTP (N-methyl-4 phenyl-1,2,3,6 tetrahydropyridine) is a neurotoxin that induces a parkinsonian syndrome. 3H-MPTP binds densely to substantia nigra specimens from neurologically normal brains. It binds just as densely to specimens from patients with idiopathic parkinsonism despite substantial losses of dopaminergic neurons in this disorder. These results accord with findings in animal studies that suggest that MPTP binds to an extraneuronal enzyme, monoamine oxidase, which converts it to a toxic metabolite that is actively taken up and accumulates inside dopaminergic neurons. An MPTP-like toxin has been postulated to be a possible cause of idiopathic parkinsonism. Preventing uptake and concentration could be one means of blocking the action of such a toxin.
MPTP(N-甲基-4-苯基-1,2,3,6-四氢吡啶)是一种可诱发帕金森综合征的神经毒素。3H-MPTP与神经功能正常的大脑黑质标本紧密结合。尽管特发性帕金森病患者的多巴胺能神经元大量丧失,但它与这些患者的标本结合同样紧密。这些结果与动物研究结果一致,动物研究表明MPTP与一种细胞外酶——单胺氧化酶结合,单胺氧化酶将其转化为一种有毒代谢产物,该代谢产物被多巴胺能神经元主动摄取并蓄积。一种类似MPTP的毒素被认为可能是特发性帕金森病的病因之一。阻止摄取和浓缩可能是阻断这种毒素作用的一种方法。